Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia

Erythromelalgia

Johns Hopkins University – Anemia University of Miami – Anemia Children’s Hospital of Philadelphia – Leukemia Steven M. Frank, MD – Anemia Atara Biotherapeutics – Epstein-Barr Virus-Associated Viremia Spectral Diagnostics (US) Inc. – Endotoxemia Hospital Ana Nery – Thromboembolism

Spinal Cord Stimulation for Refractory Pain in Erythromelalgia Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM) Carbamazapine for Inherited Erythromelalgia Patients With NaV1.7 Mutations Vascular and Neurologic Exploration of Small Nervous Fiber by Sudoscanner and QST Painful Channelopathies Study Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia